Diadema Partners »

Connect Biopharma Hldgs shares owned by Diadema Partners

Quarter-by-quarter ownership of Connect Biopharma Hldgs (CNTB) shares owned by Diadema Partners from 13F filings

Historical chart of Diadema Partners investment in Connect Biopharma Hldgs

Tip: Access up to 7 years of quarterly data

All positions including Connect Biopharma Hldgs held by Diadema Partners consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Connect Biopharma Hldgs by Diadema Partners

Quarter filed Position value Share count Share price at filing
2026-03-31 $526k 201k 2.62

More positions owned by Diadema Partners

United Therapeutics Corporation Put Option (UTHR)
Vertex Pharmaceuticals Incorporated (VRTX)
Viking Therapeutics (VKTX)
Capricor Therapeutics Com New Call Option (CAPR)
Abivax Sa Sponsored Ads (ABVX)
Liquidia Corporation Com New Call Option (LQDA)
Revolution Medicines (RVMD)
Apogee Therapeutics Call Option (APGE)
Bridgebio Pharma Note 1.750% 3/0
Incyte Corporation Put Option (INCY)
Kodiak Sciences Put Option (KOD)
Cytokinetics Com New Call Option (CYTK)
Johnson & Johnson (JNJ)
Cogent Biosciences (COGT)
Merck & Co Put Option (MRK)

View all positions for Diadema Partners

Top funds holding Connect Biopharma Hldgs

Ikarian Capital
Boothbay Fund Management
683 Capital Management
Perceptive Advisors
ADAR1 Capital Management
Richmond Brothers
Millennium Management
BML Capital Management
Knott David M Jr
Susquehanna International
Stonepine Capital Management
Propel Bio Management
Diadema Partners
Burkehill Global Management
Renaissance Technologies

View all funds holding Connect Biopharma Hldgs